Maallem S, Mutin M, González-González I M, Zafra F, Tappaz M L
Unité INSERM 433, Neurobiologie Experimentale et Physiopathologie, Faculté de Médecine RTH Laennec, Rue Guillaume Paradin, F 69372, Lyon, Cedex 08, France.
Neuroscience. 2008 Apr 22;153(1):95-107. doi: 10.1016/j.neuroscience.2008.01.047. Epub 2008 Feb 8.
Sodium-coupled neutral amino-acid transporter member 2 (SNAT2) belongs to the family of neutral amino-acid transporters. SNAT2 is encoded by the gene Slc38a2, whose expression was reported to increase in vitro in fibroblasts, endothelial and renal cells exposed to a hypertonic medium. SNAT2 tonicity-induced expression brings about cellular accumulation of amino-acid, which contributes to osmoadaptation to hypertonicity. Since brain osmoadaptation is observed in relationship to neurological disorders resulting from pathological osmotic imbalances in blood plasma, we have investigated, through immunocytochemistry, SNAT2 expression in brain of rats subjected to systemic hypertonicity. Following prolonged systemic hypertonicity (24 h), small, strongly immunolabeled elements were observed that were not present in sham-treated animals. They were evenly distributed in the gray matter, with a lower density in the forebrain and a higher density in the brain stem. However the highest density by far was observed in white matter, where they were frequently aligned in chain-like rows. These observations suggested an oligodendrocyte location that was further established by double immunofluorescent labeling, using the oligodendrocyte phenotypic markers 2'-3'-cyclic nucleotide 3'phosphodiesterase and carbonic anhydrase II. SNAT2-positive elements were found associated with oligodendrocyte cell bodies, while oligodendrocyte processes were devoid of labeling. A quantitative analysis performed in the cerebral cortex indicated that virtually all SNAT2-positive elements were associated with oligodendrocyte cell bodies and conversely that the overwhelming majority of oligodendrocytes showed SNAT2 immunolabeling. The tonicity-induced expression of SNAT2 was not observed following acute systemic hypertonicity (6 h). Our results suggest that the osmoadaptation of brain oligodendrocytes to hypertonicity relies upon amino-acid accumulation through the tonicity-induced expression of SNAT2. The possible significance of these findings in relationship to the selective loss of oligodendrocytes observed in osmotic demyelination syndrome is discussed.
钠偶联中性氨基酸转运体2(SNAT2)属于中性氨基酸转运体家族。SNAT2由Slc38a2基因编码,据报道,在暴露于高渗培养基的成纤维细胞、内皮细胞和肾细胞中,该基因的表达在体外会增加。SNAT2的张力诱导表达导致细胞内氨基酸积累,这有助于细胞对高渗环境的渗透适应。由于在与血浆病理性渗透失衡导致的神经疾病相关的情况下观察到脑渗透适应现象,我们通过免疫细胞化学方法研究了全身性高渗大鼠脑内SNAT2的表达情况。在全身性高渗持续较长时间(24小时)后,观察到了一些小的、免疫标记强烈的细胞成分,而假手术处理的动物中不存在这些成分。它们均匀分布于灰质中,在前脑密度较低,在脑干密度较高。然而,迄今为止在白质中观察到的密度最高,在白质中它们经常呈链状排列。这些观察结果提示其位于少突胶质细胞,通过使用少突胶质细胞表型标志物2'-3'-环核苷酸3'-磷酸二酯酶和碳酸酐酶II进行双重免疫荧光标记进一步证实了这一点。发现SNAT2阳性成分与少突胶质细胞胞体相关,而少突胶质细胞的突起没有标记。在大脑皮层进行的定量分析表明,几乎所有SNAT2阳性成分都与少突胶质细胞胞体相关,反之,绝大多数少突胶质细胞都显示出SNAT2免疫标记。急性全身性高渗(6小时)后未观察到SNAT2的张力诱导表达。我们的结果表明,脑少突胶质细胞对高渗环境的渗透适应依赖于通过SNAT2的张力诱导表达来积累氨基酸。讨论了这些发现与渗透性脱髓鞘综合征中观察到的少突胶质细胞选择性丢失之间可能的关系。